Revenue

With a new CEO and a booming market, mobile care provider instED is poised for major expansion. Here's what the move means for the future of healthcare.

With $13.2 billion in assets and 3.41% of all ETH, Bitmine is on a quest for market dominance. A crucial shareholder vote will decide its future.

A new report reveals the staggering personal cost of financial illiteracy is $948 per person, totaling over $246 billion for the nation in 2025.

SoftBank is buying digital infrastructure giant DigitalBridge for $4B, a bold move to own the data centers and fiber needed to power its AI ambitions.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

Purina Foundation's 2025 grants extend beyond animal welfare, funding disaster relief, youth education, and veteran support in a strategic philanthropic push.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

Genmab discontinues its 'encouraging' lung cancer drug, acasunlimab, in a bold strategic pivot to accelerate its most promising late-stage assets.

A Chinese manufacturer is solving a global branding puzzle, merging bespoke craftsmanship with industrial scale through a unique 'MaaS' production model.

In a move to protect shareholders, IP Strategy canceled a dilutive financing deal, signaling deep confidence in its $IP token reserves and the Story ecosystem.

Professional Diversity Network invests millions in an AI crypto token, a risky move signaling a dramatic pivot into the volatile world of Web3 finance.

Chip Wilson nominates three directors in a bid to remake Lululemon's board, criticizing its leadership and demanding a return to product innovation.

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

The InsurTech firm is shedding non-core units to slash debt by over 50% and double down on its AI platforms, RELI Exchange and 5minuteinsure.com.

Israeli innovator Foresight gets a major nod from Audi, showcasing its all-weather 3D vision system that could redefine autonomous vehicle safety.

Cleveland expands its AI security robot program, citing reduced crime. But as other cities watch, questions of cost, privacy, and effectiveness emerge.